Pharmaceutical

Merck reports drop in net income for fiscal 2023

Merck has reported a 15.1% decline in net income attributable to shareholders to €2.82bn in 2023 versus €3.326bn in 2022.

Mar 7, 2024 - 18:00
Merck reports drop in net income for fiscal 2023
Merck has reported a 15.1% decline in net income attributable to shareholders to €2.82bn in 2023 versus €3.326bn in 2022.
Read the original article

Tags:

Previous Article

Sionna raises $182m to double down in cystic fibrosis drug development

Next Article

Gilead and Merus enter trispecific antibody discovery deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Patients brace for insurance decisions on weight loss drugs; Indian authorities find multiple problems at pharma plants

STAT+: Pharmalittle: Patients brace for insurance decis...

Aug 3, 2023

To protect chickens from bird flu, researchers try to CRISPR in immunity

To protect chickens from bird flu, researchers try to C...

Oct 10, 2023

Sanofi completes the $1.7bn acquisition of Inhibrx

Sanofi completes the $1.7bn acquisition of Inhibrx

May 31, 2024